FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/05/052777 [Registered on: 17/05/2023] Trial Registered Prospectively
Last Modified On: 16/05/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To make and use of Anjana Shalaka Instrument in healthy person in comparison with normal Anjana Procedure 
Scientific Title of Study   Development and evaluation of the applicability of Anjana Shalaka instrument for Netraprasadana in comparison with conventional Anjana Karma in healthy volunteers. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shivkant Sharma 
Designation  Associate Professor 
Affiliation  Parul Institute of Ayurved, Parul University 
Address  OPD-108, Parul Ayurveda hospital, Shalakya tantra department, Parul institute of Ayurveda, Parul University, At Post-Limda, Tal- Waghodia, Vadodara, Gujarat 391760 India
Post-Limda, Tal- Waghodia, Vadodara, Gujarat 391760 India
Vadodara
GUJARAT
391760
India 
Phone  9124927283  
Fax    
Email  shivkants@ymail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Unnati Desai 
Designation  Post Graduate Scholar 
Affiliation  Parul Institute of Ayurved, Parul University 
Address  OPD-108, Parul Ayurveda hospital, Shalakya tantra department, Parul institute of Ayurveda, Parul University, At Post-Limda, Tal- Waghodia, Vadodara, Gujarat 391760 India
At Post-Limda, Tal- Waghodia, Vadodara, Gujarat 391760 India
Vadodara
GUJARAT
391760
India 
Phone  9913349479  
Fax    
Email  desaiuv225@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Unnati Desai 
Designation  Post Graduate Scholar 
Affiliation  Parul Institute of Ayurved, Parul University 
Address  OPD-108, Parul Ayurveda hospital, Shalakya tantra department, Parul institute of Ayurveda, Parul University, At Post-Limda, Tal- Waghodia, Vadodara, Gujarat 391760 India
At Post-Limda, Tal- Waghodia, Vadodara, Gujarat 391760 India
Vadodara
GUJARAT
391760
India 
Phone  9913349479  
Fax    
Email  desaiuv225@gmail.com  
 
Source of Monetary or Material Support  
Parul Ayurveda hospital,Parul University, At P.O-Limda, Tal- Waghodia, VADODARA-391760 
 
Primary Sponsor  
Name  Dean, Parul institute of Ayurveda 
Address  Parul Ayurveda hospital, Parul University, At P.O-Limda, Tal- Waghodia, VADODARA-391760 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Unnati Desai  Parul institute of Ayurveda  OPD-108,Parul Ayurveda hospital, Shalakya tantra department,Parul University, At P.O-Limda, Tal- Waghodia, VADODARA-391760 Vadodara GUJARAT
Vadodara
GUJARAT 
9913349479

desaiuv225@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy volunteers who are willing for therapy 
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmProcedure-a~jjanam, अंजनम् (Procedure Reference: Sushruta samhita, Uttartantra , Chapter 18, Procedure details: Volunteer is informed about the procedure and made to lie down comfortably. Application of Anjana Dravya into the conjunctival sac using newly developed Suvarna Anjana Shalaka instrument. Ask volunteer to rotate his eyes after the application of Anjana done keeping the eyes closed. Leave it till cessation of tearing. Prakshalana (Irrigation of eyes) with water. Complete rest for the volunteer with eyes closed for 5 min.)
(1) Medicine Name: Ghrita-Madhu, Reference: Sushruta Samhita, Uttartantra, Chapter 18, Shloka 56, Route: Ocular, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 0.45(g), Frequency: od, Duration: 15 Days
2Intervention ArmProcedure-a~jjanam, अंजनम् (Procedure Reference: Sushruta samhita, Uttartantra , Chapter 18, Procedure details: Volunteer is informed about the procedure and made to lie down comfortably. Application of Anjana Dravya into the conjunctival sac using Anjana Shalaka (Conventional method). Ask volunteer to rotate his eyes after the application of Anjana done keeping the eyes closed. Leave it till cessation of tearing. Prakshalana (Irrigation of eyes) with water. Complete rest for the volunteer with eyes closed for 5 min.)
(1) Medicine Name: Ghrita-Madhu, Reference: Sushruta Samhita, Uttartantra, Chapter 18, Shloka 56, Route: Ocular, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 0.45(g), Frequency: od, Duration: 15 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Both 
Details  Having good ocular health means that vision is at least 6/6 and the eyes are diseasefree.

Age between 18-35 years, irrespective of gender, caste, religion.

Those who are willing for treatment and ready to give consent as per requirement.

Nirama lakshana of eyes. 
 
ExclusionCriteria 
Details  Patients with ocular manifestations due to serious systemic illness.

Patients with any sign and symptoms mentioned in both classic literature and modern texts like blurred vision, headache, eye strain, watering of eyes, corneal pathologies.

Patient underwent any of the ophthalmic surgeries.

Those who are contraindicated for Anjana. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Development of Anjana Shalaka instrument for Netraprasadana in healthy volunteers.  6-8 months 
 
Secondary Outcome  
Outcome  TimePoints 
Applicability of newly developed Anjana Shalaka instrument for Netraprasadana in healthy volunteers.  6-8 months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/09/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
In Ayurveda, Anjana is described as one among the kriyakalpa. 
We acquire doubtless knowledge with the help of Indriya (sense organ) and out of five indriyas, the prime sense organ is eye. 
We can prevent our vision by including such therapies in over daily schedule. Netra means eye and application of various medical formulations to eye is called as Anjana.
Tremendous importance has been given to Anjana both in healthy person and as well as in ophthalmic patients. The therapy is quite beneficial for the relaxation of eyes and the treatment of various ailments related to eyes.
Today, we have developed technologies which are used presently by all age group, they use technology for longer hours, which is a highly vision demanding task. Hence, there is a need to develop a therapy which can help to prevent our eye health. So, we are trying to modify Anjana karma by instrument which can be used by every person in their daily busy schedule and the Anjana Shalaka instrument has such requirement which can fulfil the efficacy of conventional Anjana karma (Anjana procedure).

 
Close